Assessing the risk of developing psychosis using computer-based methods
1/5 CAPER: Computerized Assessment of ProdromE Risk
This study is working on a new online tool to help spot early signs of psychosis in people, making it easier for those at risk to get the support they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10808142 on NIH RePORTER |
What this research studies
This research aims to improve the early identification of individuals at clinical high risk for psychosis by developing a new assessment tool that utilizes computer-based tasks. These tasks will be designed to correlate with psychosis symptoms and the underlying neurobiological mechanisms. The study will recruit participants from various backgrounds, including those showing early signs of psychosis, to evaluate the effectiveness of this new assessment method compared to traditional interviews. By making these assessments accessible online, the research seeks to facilitate widespread screening for those at risk.
Who could benefit from this research
Good fit: Ideal candidates include individuals showing early signs of psychosis, help-seeking individuals, and healthy controls for comparison.
Not a fit: Patients who are not experiencing any symptoms of psychosis or related mental health issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate identification of individuals at risk for psychosis, potentially improving their treatment outcomes.
How similar studies have performed: Previous research has shown promise in using machine learning and computer-based assessments for predicting mental health outcomes, indicating potential success for this approach.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Gold, James M. — University of Maryland Baltimore
- Study coordinator: Gold, James M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.